메뉴 건너뛰기




Volumn 447, Issue 1-2, 2013, Pages 70-74

Needle-free intravaginal DNA vaccination using a stearoyl oligopeptide carrier promotes local gene expression and immune responses

Author keywords

Artificial cell penetrating peptide; CpG ODN; Local immunity; Needle free injector; Vaginal DNA vaccine

Indexed keywords

ARGININE; CPG OLIGODEOXYNUCLEOTIDE; CYSTEINE; DISULFIDE; DNA VACCINE; DRUG CARRIER; HISTIDINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; STEAROYL OLIGOPEPTIDE; UNCLASSIFIED DRUG;

EID: 84874940571     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.02.018     Document Type: Article
Times cited : (19)

References (14)
  • 3
    • 0037464419 scopus 로고    scopus 로고
    • Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device
    • Z. Cui, L. Baizer, and R.J. Mumper Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device J. Biotechnol. 102 2003 105 115
    • (2003) J. Biotechnol. , vol.102 , pp. 105-115
    • Cui, Z.1    Baizer, L.2    Mumper, R.J.3
  • 4
    • 0025601863 scopus 로고
    • Epidemiology of sexually transmitted diseases: The global picture
    • A. De Schryver, and A. Meheus Epidemiology of sexually transmitted diseases: the global picture Bull. WHO 68 1990 639 654
    • (1990) Bull. WHO , vol.68 , pp. 639-654
    • De Schryver, A.1    Meheus, A.2
  • 7
    • 47049118557 scopus 로고    scopus 로고
    • Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine
    • T. Kanazawa, Y. Takashima, S. Hirayama, and H. Okada Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine Int. J. Pharm. 360 2008 164 170
    • (2008) Int. J. Pharm. , vol.360 , pp. 164-170
    • Kanazawa, T.1    Takashima, Y.2    Hirayama, S.3    Okada, H.4
  • 8
    • 75749134156 scopus 로고    scopus 로고
    • Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses
    • T. Kanazawa, Y. Takashima, Y. Shibata, M. Tsuchiya, T. Tamura, and H. Okada Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses J. Pharm. Pharmacol. 61 2009 1457 1463
    • (2009) J. Pharm. Pharmacol. , vol.61 , pp. 1457-1463
    • Kanazawa, T.1    Takashima, Y.2    Shibata, Y.3    Tsuchiya, M.4    Tamura, T.5    Okada, H.6
  • 10
    • 84867319576 scopus 로고    scopus 로고
    • Vaginal DNA vaccination against infectious diseases transmitted through the vagina
    • T. Kanazawa, Y. Takashima, and H. Okada Vaginal DNA vaccination against infectious diseases transmitted through the vagina Front. Biosci. (Elite Ed) 1 2012 2340 2353
    • (2012) Front. Biosci. (Elite Ed) , vol.1 , pp. 2340-2353
    • Kanazawa, T.1    Takashima, Y.2    Okada, H.3
  • 11
    • 0030582188 scopus 로고    scopus 로고
    • Global burden of the HIV pandemic
    • T.C. Quinn Global burden of the HIV pandemic Lancet 348 9020 1996 99 106
    • (1996) Lancet , vol.348 , Issue.9020 , pp. 99-106
    • Quinn, T.C.1
  • 12
  • 13
    • 77956220454 scopus 로고    scopus 로고
    • Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing
    • K. Tanaka, T. Kanazawa, T. Ogawa, Y. Takashima, T. Fukuda, and H. Okada Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing Int. J. Pharm. 398 2010 229 238
    • (2010) Int. J. Pharm. , vol.398 , pp. 229-238
    • Tanaka, K.1    Kanazawa, T.2    Ogawa, T.3    Takashima, Y.4    Fukuda, T.5    Okada, H.6
  • 14
    • 79551488608 scopus 로고    scopus 로고
    • A novel bio-reducible gene vector containing arginine and histidine enhances gene transfection and expression of plasmid DNA
    • K. Tanaka, T. Kanazawa, T. Ogawa, Y. Suda, Y. Takashima, T. Fukuda, and H. Okada A novel bio-reducible gene vector containing arginine and histidine enhances gene transfection and expression of plasmid DNA Chem. Pharm. Bull. 59 2011 202 207
    • (2011) Chem. Pharm. Bull. , vol.59 , pp. 202-207
    • Tanaka, K.1    Kanazawa, T.2    Ogawa, T.3    Suda, Y.4    Takashima, Y.5    Fukuda, T.6    Okada, H.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.